Risk factors associated with recurrent venous thromboembolism after a first cerebral venous thrombosis event: A cohort study. Issue 178 (June 2019)
- Record Type:
- Journal Article
- Title:
- Risk factors associated with recurrent venous thromboembolism after a first cerebral venous thrombosis event: A cohort study. Issue 178 (June 2019)
- Main Title:
- Risk factors associated with recurrent venous thromboembolism after a first cerebral venous thrombosis event: A cohort study
- Authors:
- Pires, Giselli S.
Ribeiro, Daniel D.
Oliveira, João A.Q.
Freitas, Luís C.
Vaez, Rodrigo
Annichino-Bizzacchi, Joyce M.
Morelli, Vânia M.
Rezende, Suely M. - Abstract:
- Abstract: Background: Cerebral venous thrombosis (CVT), although rare, is potentially fatal. Few studies have investigated risk factors associated with recurrent venous thromboembolism (VTE) after a first CVT event of which most are from Caucasian populations. The aim of this study was to evaluate risk factors associated with recurrent VTE after a first CVT event in a South American-population. Patients/methods: In this cohort, multicenter study, patients aged >18 years and objectively-diagnosed with CVT were included, with follow-up starting after discontinuing anticoagulant therapy. The primary outcome was symptomatic VTE recurrence at any venous site. Results: We included 203 patients with a median age of 30.8 (interquartile range [IQR], 24.7–40.9) years and a follow-up of 3.0 (IQR, 1.2–5.6) years. Most patients (86.2%) were women, and among those of reproductive age (n = 162), 65.4% developed CVT during oral contraceptive use, and 9.2% during pregnancy/puerperium. Thirteen patients (6.9%) developed VTE recurrence after a first CVT, yielding an overall rate of 1.6/100 patient-years (95% confidence interval [CI], 0.8–2.8). Recurrence rate was higher in males (4.6/100 patient-years; 95% CI, 1.2–11.7) than in females (1.2/100 patient-years; 95% CI, 0.6–2.4), and in patients with factor V Leiden mutation (9.2/100 patient-years; 95% CI, 1.1–33.1) than in those without it (1.2/100 patient-years; 95% CI, 0.5–2.4). Conclusions: VTE recurrence after a first CVT was low. In spiteAbstract: Background: Cerebral venous thrombosis (CVT), although rare, is potentially fatal. Few studies have investigated risk factors associated with recurrent venous thromboembolism (VTE) after a first CVT event of which most are from Caucasian populations. The aim of this study was to evaluate risk factors associated with recurrent VTE after a first CVT event in a South American-population. Patients/methods: In this cohort, multicenter study, patients aged >18 years and objectively-diagnosed with CVT were included, with follow-up starting after discontinuing anticoagulant therapy. The primary outcome was symptomatic VTE recurrence at any venous site. Results: We included 203 patients with a median age of 30.8 (interquartile range [IQR], 24.7–40.9) years and a follow-up of 3.0 (IQR, 1.2–5.6) years. Most patients (86.2%) were women, and among those of reproductive age (n = 162), 65.4% developed CVT during oral contraceptive use, and 9.2% during pregnancy/puerperium. Thirteen patients (6.9%) developed VTE recurrence after a first CVT, yielding an overall rate of 1.6/100 patient-years (95% confidence interval [CI], 0.8–2.8). Recurrence rate was higher in males (4.6/100 patient-years; 95% CI, 1.2–11.7) than in females (1.2/100 patient-years; 95% CI, 0.6–2.4), and in patients with factor V Leiden mutation (9.2/100 patient-years; 95% CI, 1.1–33.1) than in those without it (1.2/100 patient-years; 95% CI, 0.5–2.4). Conclusions: VTE recurrence after a first CVT was low. In spite of the limitation of small sample size, male sex and factor V Leiden mutation were the only factors associated with a significant higher risk of recurrent VTE after a first CVT in a multivariate analysis. Highlights: Cerebral venous thrombosis (CVT) is a rare presentation of venous thromboembolism (VTE). VTE recurrence after CVT has rarely been studied in admixed populations. A total of 13/189 (6.9%) patients developed VTE recurrence after a first CVT. Recurrence rate was higher in males and in patients with factor V Leiden mutation. … (more)
- Is Part Of:
- Thrombosis research. Issue 178(2019)
- Journal:
- Thrombosis research
- Issue:
- Issue 178(2019)
- Issue Display:
- Volume 178, Issue 178 (2019)
- Year:
- 2019
- Volume:
- 178
- Issue:
- 178
- Issue Sort Value:
- 2019-0178-0178-0000
- Page Start:
- 85
- Page End:
- 90
- Publication Date:
- 2019-06
- Subjects:
- Cerebral venous thrombosis -- Recurrence -- Risk factor -- Venous thromboembolism -- Epidemiology
Thrombosis -- Periodicals
616.135 - Journal URLs:
- http://www.sciencedirect.com/science/journal/00493848 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.thromres.2019.04.008 ↗
- Languages:
- English
- ISSNs:
- 0049-3848
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 8820.365000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 10390.xml